First Generic of Symbicort Receives FDA Approval

TUESDAY, April 12, 2022 -- The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news